chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Was stressed and run down in weeks prior to shot (taking care of mother dying of cancer who passed 04//01/21) so was not able to determine if experiencing side effects of just continued fatigue. Sore arm, bruised. Monday evening 04/12/21 felt sick, nauseous. Unusual for me. Continuing to feel sick each day since then and called in sick to work today. When I move around I feel worse. My chest feels like I am on the verge of getting really sick. I can breathe but just do not feel good. Feel worse when having a conversation with people. Feel better resting. I have no fever. My blood pressure and heart rate are normal. This is the sickest I have felt since before the pandemic. I called a nurses hotline yesterday and was told to call 911 is I had chest discomfort. I do not feel sick enough to call 911 and could drive myself if I need to go to the hospital. Best way to describe my symptoms is feel like I am on the verge of getting a bad chest cold. Had a headache last night and did not take anything. Woke up in the middle of the night with a very painful headache and took 2 Tylenol which made the headache subside. I have been feeling worse each day since Monday. Today is Thursday. Am wondering if I have COVID-19 and have called a clinic to schedule a COVID test that will be paid for by my work. Am waiting for a return call. All I know is that I feel sick and was not feeling this way before having the vaccine.
Was seen for 15 mo well child visit 10/28/2011 received DTaP, HIB, PCV 13 and influenza vaccines approximately 5pm exam was normal. Patient was at daycare 10/31/11 and found to be unresponsive after being put down for a nap. Brought to ER, pronounced dead after unsuccessful resuscitation attempt.
Two weeks after immunizations given on 9/29/05, client experienced pain in left arm and shoulder.  No pain or redness at Td site.  Client also complained of pain in neck, spine, buttocks, and back of legs.  Client rode 10/4/-10/7 on church bus to help hurricane victims.  Patient is part of a SELECT Selenium and Vitamin E Cancer Prevention Trial - drug is Proscar.  Saw private MD for his opinion on the above left shoulder and arm pain.  MD's report states:  afebrile, BP 104/59, pulse 66.  Alert and in no distress.  Impression:  general fatigue; additional aches and muscle strains involving other areas besisde left shoulder and arm.  Diagnosis:  mild left shoulder tendonitis unrelated to Td vaccination.
2nd dose 2 weeks after 1st; This non-serious case was reported by a consumer via call center representative and described the occurrence of drug dose administration interval too short in a 57-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included diabetes. Concomitant products included VARICELLA ZOSTER VACCINE RGE (CHO) (SHINGRIX).   On an unknown date, the patient received the 2nd dose of Shingrix (left arm). On an unknown date, an unknown time after receiving Shingrix, [the patient experienced drug dose administration interval too short (Verbatim: 2nd dose 2 weeks after 1st).The outcome of the drug dose administration interval too short was unknown.   Additional Information: GSK Receipt Date: 07-MAR-2023. The patient's wife stated that her husband received second dose of Shingrix 2 weeks later his first dose. She did not have any further information about the vaccine in terms of lot number or expiration.  The reporter consented to follow up. The patient received 2nd dose of Shingrix, earlier than the recommended interval, which led to shortening of vaccination schedule.
This initial serious spontaneous case, was received on 27-Nov-2017, from other non-health professional, concerning a patient of unspecified age and gender. On an unspecified date, the patient was administered with INN Flu Vaccine Seasonal (dose, route of administration, anatomical location, batch number, expiry date, trade name, manufacturer: not reported). On an unspecified date, after administration of flu vaccine, the patient experienced "paralyzed legs" for several days. The outcome of the event was not reported.
Wasn't feeling well the next morning after I was up for 30min.. Went back to bed. Started having flu like symptoms a hour later.  It gradually intensified over the next few hours. Had EXTREME body aches/pain, fever, chills, headache, and slight swelling at the injection site. It continued for 24 hrs. On the second day I still had a headache, lethargic, slight appetite loss, and bad joint pain. I'm not sure about the fever. I took Tylenol every 4 hrs for the first two days. On the third day most of the aches were gone, no fever, no chills, but still had slight appetite loss, lethargy, and just didn't feel good enough to be out of bed. On the fourth day I still didn't feel good. I missed 3 1/2 days of work. By day 4 I had a lot of swelling in my arm with a knot and itching.
Shortness of breath; This is a spontaneous report from a contactable consumer (patient's mother). This is the 3 of 8 reports. A 52-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on unknown date in Jan2021 (at the age of 52-year-old) as dose 1, single for COVID-19 immunisation. Medical history included ongoing Thyroid condition from unknown date in 2021(it was reported as she was in her first year of being diagnosed with thyroid condition started this year), ongoing menopause, Exercises daily (it was reported as she is strong, athlete, exercises daily rides her bike or walks after work, is pretty strong), ongoing endometriosis, diagnosed allergies, compromised immune status, respiratory illness, genetic / chromosomal abnormalities, endocrine abnormalities, obesity. Family Medical History Relevant to AE(s) was None. The patient's concomitant medications included ongoing Unknown product from 2021. History of all previous immunization with the Pfizer vaccine considered as suspect was reported as none. Additional vaccines administered on same date of the Pfizer Suspect was reported as none. Prior Vaccinations (within 4 weeks) was reported as none. Patient family medical history was reported as none. On unknown date in Jan2021 the patient experienced shortness of breath. The patient waited in observation after the first dose of the Pfizer Covid-19 Vaccine for the 15 or 20 minutes, and this event started while she was driving home after that first dose of the Pfizer Covid-19 Vaccine; so within an hour or 2. The event was not long-lasting, she had to stop driving, pull off the road and called a nurse. Nurse told her to get over the counter Zyrtec (Zyrtec Lot/NDC/UPC/Expiry: not provided) for the shortness of breath and the patient did take it and drove home, and the Zyrtec worked. When she got the second dose of the Pfizer Covid-19 Vaccine shot she told the people who were giving the vaccinations she had that reaction with the first dose; so they put her in a little room with a bed for observation after the second dose. They watched her for the first hour after second vaccination because she was alone and she didn't get a reaction, no reaction with the second dose. Relevant tests reported as none. The event did not cause visit to Emergency Room or Physician Office. Outcome of the event was recovered on unknown date in Jan2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Rcv'd DPT & OPV vax. on 1/3/91.On 1/12/91, dvlped fussiness and fever.On 1/13/91, was seen w/ bulging fontanelle.Ultm'ly has had exten. eval. for static encephalopathy;with effects on memory, lang.,visual-motor integ.,ADHD,fine motor def. 60 day follow-up received on 9/26/00 states the pt has migraines with neurological deficits.
Chills, skin tingling, fatigue, headache, nausea that resolved after 36 to 48 hours.  Treated headache with 1000 mg of tylenol.
Pertussis; This case was reported by a consumer via interactive digital media and described the occurrence of pertussis in a child patient who received DTPa (DTPa vaccine) for prophylaxis.   On an unknown date, the patient received DTPa vaccine at an unknown dose. On an unknown date, unknown after receiving DTPa vaccine, the patient experienced pertussis (serious criteria GSK medically significant). On an unknown date, the outcome of the pertussis was unknown.   It was unknown if the reporter considered the pertussis to be related to DTPa vaccine.  Additional details were provided as follows: The case has been reported by patient's mother. The age at vaccination was not reported. Till the time of reporting, the patient had not received the final DTPa and had contracted. The case was considered as mild because, the patient had been received the vaccination upto the point. This case has been linked with case US2019AMR167025 reported by the same reporter.
Seen in ER on 12/1/02 with seizure T 102.5.  She left ER with a diagnosis of UTI and febrile seizure.  Day later the urine culture showed no growth and BACTRIM was discontinued by the pediatrician in the office.
Patient complained of swelling, redness, pain at injection site right deltoid. Right upper arm warm. Questionable cellulitis. Complained of chills. Patient applied warm heat; improvement noted. Cellulitis resolving.
sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     Concurrent medical conditions included Cholesterol and Thyroid disorder NOS. Concomitant products included ATORVASTATIN for Cholesterol, LEVOTHYROXINE for Thyroid disorder NOS, VITAMIN D [VITAMIN D NOS], ACETYLSALICYLIC ACID (BABY ASPIRIN) and VITAMIN C [ASCORBIC ACID] for an unknown indication.    On 17-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Apr-2021, the patient experienced PAIN IN EXTREMITY (sore arm). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Benadryl was taken as treatment medication.   This case was linked to MOD-2021-148714 (Patient Link).
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. On or about 09-SEP-2009, the patient was inoculated with ZOSTAVAX at a clinic as recommended for routine adult health maintenance and for the prevention of shingles (lot #, dose and route not provided). The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain of herpes zoster.  In or about May 2016, the patient was treated at the same clinic and was diagnosed with herpes zoster, or shingles. As a direct and proximate result of ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
First felt a surge of heat rising in the middle of her chest, when it dissipated she felt tightness on her chest.
This spontaneous report as received from a Nurse practitioner refers to a patient of unknown gender and age who on an unknown date, was vaccinated with PROQUAD (Merck) (dose, route and lot # not provided). Nurse Practitioner reports that one children received dose of PROQUAD (Merck) that were stored at an unknown temperature for an unknown period of time. No adverse effect reported. No other information provided. This is one of several reports from same source. Additional information has been requested.
Presented to ED on 6/11 with nausea and vomiting, along with weakness.
Information has been received from a 73 year old female consumer with no medical history and no known drug allergies who on 23-JUN-2010 was vaccinated with a dose of ZOSTAVAX (Merck). Concomitant therapy included aspirin and chondroitin sulfate sodium (+) glucosamine sulfate. The day after, on 24-JUN-2010 the patient noticed redness and irritation around the injection site. The patient said it has been itching her pretty badly as well. The patient did not seek any medical attention. No laboratory tests were performed. At the time of the report, the patient had not recovered. No further information is available.
Fever began night of injection (Thursday) and went up to 101.8 degrees. Treated with Tylenol. Shingrix injection site began to swell and redden overnight. Fever continued all the following day  (Friday, 10/08/2021) being about 99.8 with Tylenol. General malaise and sleepiness all day diminishing by about 8pm Friday night. Redness at Shingrix injection site increased to 3"x1" with hard knot, heat, and swelling; some itchiness. Red, hard, hot, swelling lasted at least thru Saturday 10/09/2021. (time of this report, so probably will last another day or more)
This spontaneous report as received from a physician refers to a 18 month old female patient. On 01-APR-2017 the patient was vaccinated with VARIVAX, .5 ml, subcutaneous for prophylaxis. On 2017 the patient experienced rash. The outcome of rash was reported as recovered/resolved.
sore left arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore left arm) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 02L20A) for COVID-19 vaccination.     Concurrent medical conditions included Cholesterol, Blood pressure and Heart rate high. Concomitant products included CALCIUM, CYANOCOBALAMIN (VITAMIN B12 [CYANOCOBALAMIN]) and COLECALCIFEROL (VIT D3) for an unknown indication.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jan-2021, the patient experienced VACCINATION SITE PAIN (sore left arm). On 17-Jan-2021, VACCINATION SITE PAIN (sore left arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications reported also included cholesterol medication, blood pressure medication and medication for fast heart beat.
ROUND, RED AREA ABOUT 2.5 INCHES IN DIAMETER AND ITCHY
SWELLING, REDNESS, TENDERNESS, LOCALIZED INJECTION SITE REACTION, FEVERISH - BUT ONLY LOCAL, NOT SYSTEMIC.  PATIENT FELT LETHARGIC AND EXCESSIVELY WEAK FOR DAYS.
Pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnant) in a 38-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     Concurrent medical conditions included Hashimoto's disease since 2001. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for Hashimoto's disease, MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for for pregnancy.    On 08-Feb-2021 at 9:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 24-Sep-2020 and the estimated date of delivery was 18-Jul-2021. On 08-Feb-2021, the patient experienced EXPOSURE DURING PREGNANCY (Pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  nineteenth week of the pregnancy. The delivery occurred on an unknown date.  On 08-Feb-2021, EXPOSURE DURING PREGNANCY (Pregnant) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Nov-2020, Pregnancy test: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient reported her pregnancy is through In Vitro Fertilization since her husband is quadraplegic
Employee here with COVID vaccine reaction was given the vaccine on 12/30/20 in left upper arm, noticed the area was red on 01/07/21. The area is red, swollen, warm to the touch, itching. The area measures 6 X 4.5cm borders not clearly defined. Explained conservative measures including cool compresses, if approved by PCP taking OTC IBU and antihistamines and hydrocortisone cream. Explained signs of cellulitis including skin tightness and red streaking, informed if the area worsens after trying conservative measure to go for further care with either PCP or walk in clinic. Employee verbalized understanding and agrees with plan.
headache; This is a spontaneous report from a contactable consumer (patient). A 65-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 19Jan2021 10:15 AM at single dose in left arm for COVID-19 immunisation. The most recent COVID-19 vaccine was administered at workplace clinic. Patient age at vaccination is 65 years. No other vaccine was given within 4 weeks prior to the COVID vaccine. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 29Dec2020 06:15 PM, at single dose in right arm. Medical history included high blood pressure and high cholesterol. The patient has no allergies to medications, food, or other products/known allergies. The patient received unspecified concomitant medications. On 20Jan2021 on 01:00 PM the patient experienced a headache after second dose, it started about 24 hours after the 2nd dose. Still have it on day 2, but is not severe. Using generic Tylenol to treat it. The event was reported as non serious. The event was resolving. Prior to vaccination the patient was not diagnosed with COVID-19.  Since the vaccination, the patient has been tested for COVID-19 SR008138-Salivary, SARS-COV-2 COVID-19 test on 14Jan2021 with negative result.
I had chest pain; my left arm went numb; Pain is always there. Sometimes I feel it in my arm; I get short of breath; This is a spontaneous report from a contactable consumer (patient). A 43-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EW0153, Expiration date: not reported, Age at vaccination: 43-year-old) via an unspecified route of administration in right arm on 08Apr2021 04:00 PM as single dose for COVID-19 immunization. The patient medical history included seasonal allergies. Concomitant medications included Zyrtec D, Mucinex DM and Flonase. On 21Jul2021, patient experienced chest pain, numbness of extremities, pain, short of breath. Lab test included EKG, blood work in the ER checking for Heart attack, Echo and stress test, CT of my chest, PFT and 6 min walk for my lungs. Adverse event resulted in: Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. Treatment as antibiotics received for events. No other vaccine was administered in four weeks. Covid was not present prior vaccination. Patient had no known allergies. The outcome of events was recovered on an unknown date with sequel.  Follow-up attempts are completed. No further information is expected.
Moaning, stiffened early morning and then fell back to sleep. (Possible seizure.)
has a sore arm with some itching as of today 29Sep2021only her arm is still affected; The following day everything hurt but her hair, she could stay up a half hour then; fever of 99.2; joint pain; bad headache; Her 3rd injection was on 26Sep2021 at 11:30AM that day she had a sore arm; she started feeling bad; she hardly ate or drank all day; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (she started feeling bad), DECREASED APPETITE (she hardly ate or drank all day), VACCINATION SITE PRURITUS (has a sore arm with some itching as of today 29Sep2021only her arm is still affected), MYALGIA (The following day everything hurt but her hair, she could stay up a half hour then) and PYREXIA (fever of 99.2) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Sep-2021 at 11:30 AM, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Sep-2021, the patient experienced FEELING ABNORMAL (she started feeling bad), DECREASED APPETITE (she hardly ate or drank all day), MYALGIA (The following day everything hurt but her hair, she could stay up a half hour then), PYREXIA (fever of 99.2), ARTHRALGIA (joint pain), HEADACHE (bad headache) and VACCINATION SITE PAIN (Her 3rd injection was on 26Sep2021 at 11:30AM that day she had a sore arm). On 29-Sep-2021, the patient experienced VACCINATION SITE PRURITUS (has a sore arm with some itching as of today 29Sep2021only her arm is still affected). On 28-Sep-2021, FEELING ABNORMAL (she started feeling bad), DECREASED APPETITE (she hardly ate or drank all day), MYALGIA (The following day everything hurt but her hair, she could stay up a half hour then), PYREXIA (fever of 99.2), ARTHRALGIA (joint pain), HEADACHE (bad headache) and VACCINATION SITE PAIN (Her 3rd injection was on 26Sep2021 at 11:30AM that day she had a sore arm) had resolved. At the time of the report, VACCINATION SITE PRURITUS (has a sore arm with some itching as of today 29Sep2021only her arm is still affected) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 99.2 (High) fever of 99.2..         No concomitant medication reported. No treatment information was provided.   This case was linked to MOD-2021-335962, MOD-2021-335979, MOD-2021-335962 (Patient Link).
Patient informed me yesterday that his pheumonia vaccine in 2019 has given him arm and shoulder pain ever since the injection.
Pt received Twinrix #2 on 8/19/04 without problem-Afterwards, the nurse noted that the expiration date was 7/5/04.
Abdominal pain 7 days post vaccine. Diagnosed with appendicitis 9 days post vaccine.
headache, alleviated with otc Tylenol and ibuprofen, but comes back after medication wears off. Dizziness not alleviated by rest.
Headaches, dizziness, nausea started around 5pm. By 10pm did manual BP, was 84/48. Chills and mild sweats overnight and BP in AM was 90/50s despite 2L water intake overnight. Fatigue and generalized aches by 0500 on 12/24/20. No symptoms prior to vaccine. Of note I work as Hospitalist with ER and inpatient wards- always using ventilator mask.
Initial unsolicited report received from a healthcare professional via partner company (Pfizer) (Manufacturer Report Number: 2016005924) on 15 January 2016. This case involves a female patient (age not reported) who was vaccinated with a dose of Flu shot (batch number, route and site of administration not reported) on an unspecified date. The patient's medical history and concomitant medications were not reported. On an unspecified date, following the vaccination, the patient had experienced allergy to vaccine. Laboratory data and corrective treatment were not reported. The outcome of event was not reported. List of documents held by sender: none.